News · Approval
1,551 stories
Sep 11, 26Cullinan, Taiho showcase 6-month survival benefit in phase 3 trial for advanced lung cancer
Sep 11, 26The future of RAS inhibitors
Sep 11, 26STAT+: Novartis, Novo Nordisk drug failures will likely ‘pop a hole in the balloon’ of the field
Sep 10, 26STAT+: Can AI save rural health care?
Sep 10, 26Biohaven takes another hit as FDA pauses enrollment in pivotal trials for embattled epilepsy drug
Sep 10, 26Drugmakers cherry pick launch regions as MFN creates 'policy environment like an earthquake'
Sep 9, 26CEO O’Day tells Fierce how Gilead’s cancer, inflammation expansion has reached ‘critical mass’